Development

Latest News

digestive tract | Image credit: sdecoret - stock.adobe.com
Celltrion, Samsung Bioepis Unveil New Biosimilar Data in CD, UC at ECCO 2024

February 23rd 2024

At the Congress of European Crohn’s and Colitis Organisation (ECCO), Celltrion and Samsung Bioepis presented new finding from their respective biosimilar analyses, demonstrating positive safety and efficacy measures for the biosimilars as treatments for Crohn disease (CD) and ulcerative colitis (UC).

CFB podcast banner
Exploring the Biosimilar Horizon: Julie Reed's Predictions for 2024

February 18th 2024

Dermatologist examining skin | Image Credit: fusssergei - stock.adobe.com
Biosimilar Candidate CT-P43 Shows Biosimilarity With Ustekinumab Originator in Plaque Psoriasis

February 13th 2024

syringes | Image credit: anton - stock.adobe.com
BioRationality: Bringing the FDA and the USP Together to Revolutionize Biosimilars

February 5th 2024

FDA role | Image credit: wladimir1804 - stock.adobe.com
BioRationality: It Takes 4 to Tango—How US Entities Can Make Biosimilars Accessible

January 22nd 2024

Video Interviews
Podcasts
CFB podcast banner
CFB podcast banner
"SEEING EYE TO EYE:  Exploring Different Perspectives on Ophthalmology Biosimilars SEEING EYE TO EYE:  Exploring Different Perspectives on Ophthalmology Biosimilars" with the CfB logo and an image of an eye
cfb podcast banner
CfB podcast banner
CfB podcast banner

More News

© 2024 MJH Life Sciences

All rights reserved.